Internal Server Error

List of Pfizer's Acquisitions

lockFilter this list
Pfizer has completed 41 acquisitions. Peak activity occurred in 2008 and 2007 with 4 acquisitions each, followed by 3 in 2022. These acquisitions span 5 countries, including United States (35), United Kingdom (3), and Canada (1), and have involved 22 distinct sectors. The sectors with the most acquisitions are Oncology (7), Diversified Pharmaceuticals (5), and Infectious Diseases (4). Over the last five years (2020-2025), the average number of acquisitions per year has been 1.6, with 0 completed so far in the current calendar year. The most recent acquisition was Metsera, a biopharmaceutical company focused on medicines for obesity and metabolic diseases, founded in 2022 and based in New York City. This acquisition was finalized in September 2025 for $7.3B.

Here's the year on year acquisition history of Pfizer:

Year on year acquisition history of Pfizer20252023202220212019Acquisitions Round Date (Yearly)01234
  • Number of Total Acquisitions
Year
# Acquisitions
2025
1
2023
1
2022
3
2021
3
2019
2
2016
3
2015
2
2014
2
2012
3
2011
2
2010
3
2008
4
2007
4
2006
2
2005
3
2004
1
2003
1
2002
1

Recent acquisitions by Pfizer

Pfizer's most recent acquisition - Metsera is a Biopharmaceutical company focusing on medicines for obesity and metabolic diseases, founded in 2022 and located in New York City. Pfizer acquired it in September 2025 for a price of $*****.

Here is the list of all acquisitions by Pfizer sorted by the latest acquisition date:

Acquired on
Acquired Company
Acquisition Price
Facilitators
Stake Acquired
Acquisition Multiple
Sep 22, 2025
{irw
dbmt
45
209
Mar 13, 2023
nuum
{dbq
46
721
Aug 08, 2022
jurv
boku
84
137
May 10, 2022
opzd
czkf
38
390
Apr 07, 2022
lnnf
{nwy
58
171

View the full list of acquisitions

Sign Up for Free

News related to Pfizer's acquisitions

lockFilter this list

Media has covered Pfizer for a total of 323 events in the last 1 year, 47 of them have been about acquisition activity.

View More Pfizer Recent News

FAQs about Acquisitions by Pfizer

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford